Table 2.

Comparison of biomarker levels between Non-rupture group and Rupture group in patients with ACS.

	Rupture group (n = 42)	Non-rupture group (n = 43)	p-value
Troponin I (ng/mL)	0.21 (0.12–5.82)	0.19 (0.1–0.92)	0.7244
Peak CK-MB (ng/mL)	13.39 (2.23–182.8)	2.69 (1.65–5.19)	0.0016
High-sensitivity CRP (mg/L)	1.35 (0.62–3.94)	1.08 (0.63–4.13)	0.6635
sLOX-1 (pg/mL)	227.87 (49.45–607.3)	51.7 (19.6–104.3)	< .0001
NGAL (ng/mL)	59.0 (47.2–85.9)	53.1 (43.0–63.7)	0.0932
MMP-9 (ng/mL)	13.36 (4.12–32.06)	6.45 (2.56–12.94)	0.0313

Data are presented as median (interquartile range).

ACS acute coronary syndrome, CK-MB creatine kinase-muscle/brain, CRP C-reactive protein, sLOX-1 soluble lectin-like oxidized low-density lipoprotein receptor-1, NGAL neutrophil gelatinase-associated lipocalin, MMP-9 matrix metalloproteinase-9.